Migone
Rubén A. Migone, Pittsburgh, PA US
Patent application number | Description | Published |
---|---|---|
20100081755 | Method for preparing a random copolymer with enhanced ethylene content - A polypropylene resin, useful for the production of biaxially oriented polypropylene (BOPP) film, is provided. The polymer of the present invention is a blend of high crystalline polypropylene homopolymer and a high ethylene ethylene/propylene random copolymer (RCP). The present invention also provides a method of preparing the novel resin as well as a novel BOPP film comprising the resin. | 04-01-2010 |
20100081756 | RANDOM COPOLYMER WITH ENHANCED ETHYLENE CONTENT - A polypropylene resin, useful for the production of biaxially oriented polypropylene (BOPP) film, is provided. The polymer of the present invention is a blend of high crystalline polypropylene homopolymer and a high ethylene ethylene/propylene random copolymer (RCP). The present invention also provides a method of preparing the novel resin as well as a novel BOPP film comprising the resin. | 04-01-2010 |
20100081760 | Film comprising a random copolymer with enhanced ethylene content - A polypropylene resin, useful for the production of biaxially oriented polypropylene (BOPP) film, is provided. The polymer of the present invention is a blend of high crystalline polypropylene homopolymer and a high ethylene ethylene/propylene random copolymer (RCP). The present invention also provides a method of preparing the novel resin as well as a novel BOPP film comprising the resin. | 04-01-2010 |
20110021708 | POLYPROPYLENE BLENDS FOR NON-WOVEN PRODUCTION - Polypropylene resin compositions are provided that are useful in the production of thermoformed articles and biaxially oriented polypropylene films (BOPPs), tapes and fibers. The resins of the present invention are blends of high crystalline (low solubles) polypropylene homopolymer and an ethylene/propylene random copolymer (RCP). These blends can be used to replace standard high solubles BOPP grade polypropylene homopolymers. In addition, the use of high crystalline polypropylene homopolymers in the blends imparts improved stiffness to the finished films while maintaining good processability of the blends. Such polypropylene compositions are effectively produced by in-reactor blending of a high crystalline propylene homopolymer and a propylene/ethylene random copolymer. | 01-27-2011 |
Rubén A. Migone, Pittsburgh, PA US
Patent application number | Description | Published |
---|---|---|
20110021708 | POLYPROPYLENE BLENDS FOR NON-WOVEN PRODUCTION - Polypropylene resin compositions are provided that are useful in the production of thermoformed articles and biaxially oriented polypropylene films (BOPPs), tapes and fibers. The resins of the present invention are blends of high crystalline (low solubles) polypropylene homopolymer and an ethylene/propylene random copolymer (RCP). These blends can be used to replace standard high solubles BOPP grade polypropylene homopolymers. In addition, the use of high crystalline polypropylene homopolymers in the blends imparts improved stiffness to the finished films while maintaining good processability of the blends. Such polypropylene compositions are effectively produced by in-reactor blending of a high crystalline propylene homopolymer and a propylene/ethylene random copolymer. | 01-27-2011 |
Thi-Sau Migone, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20110014190 | USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE - The invention relates to methods of preventing, treating, ameliorating and otherwise inhibiting organ or transplant rejection in a patient by administering B Lymphocyte Stimulator antagonists. In addition, therapeutic treatment regimens are provided to promote transplant tolerance in a patient following the administration of B Lymphocyte Stimulatorantagonists. | 01-20-2011 |
20110311548 | USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO TREAT ASTHMA AND OTHER ALLERGIC AND INFLAMMATORY CONDITIONS OF THE RESPIRATORY SYSTEM - The invention relates to methods of preventing, treating, and ameliorating asthma, allergen-induced respiratory symptoms, and/or an allergic or inflammatory condition of the lung or respiratory system in a patient by administering B Lymphocyte Stimulator antagonists. In addition, the invention provides a method of reducing total serum IgE levels in a patient suffering from asthma, and/or an allergic or inflammatory condition of the lung or respiratory system by administering B Lymphocyte Stimulator antagonists. The invention further provides a method of treating, preventing or ameliorating an allergen-induced airway hyper responsiveness or increase in mucus-containing cells and/or mucus accumulation or production in the airway epithelium of a patient by administering B Lymphocyte Stimulator antagonist. | 12-22-2011 |
20120014950 | Antibodies That Specifically Bind to DR3 - The present invention relates to antibodies, antibody fragments, and related molecules that specifically bind to DR3 receptors. Such antibodies have uses, for example, in the prevention, detection, diagnosis, treatment or amelioration of a disease or disorder, especially inflammatory and autoimmune diseases and other immune system disorders, such as Crohn's disease, colitis, Inflammatory Bowel Disease, arthritis, asthma, Multiple Sclerosis, atherosclerosis, and allergic disorders. The invention also relates to nucleic acid molecules encoding anti-DR3 receptor antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially inflammatory or autoimmune disorders, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that specifically bind to DR3 receptor. | 01-19-2012 |
Thi-Sau Migone, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20150322158 | USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE - The invention relates to methods of preventing, treating, ameliorating and otherwise inhibiting organ or transplant rejection in a patient by administering B Lymphocyte Stimulator antagonists. In addition, therapeutic treatment regimens are provided to promote transplant tolerance in a patient following the administration of B Lymphocyte Stimulatorantagonists. | 11-12-2015 |